Calico

Calico is a biotech company in South San Francisco, United States, founded in 2013. It has raised $2.3B across 4 rounds, most recently a $1.0B Corporate Round in June 2018.

Tackling aging, one of life's greatest mysteries

Employees
201–500
Founded
2013
Business Model
B2B
Total Funding
$2.3B
Last Round
$1.0B Corporate RoundJun 2018
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 3 investors for this company. The full record is or through the API.

About

Calico is a research and drug development company dedicated to understanding the biology of aging and translating those insights into potential medicines. The organization integrates basic research, computational biology, machine learning, and advanced laboratory technologies—including cryo-EM, genomics, and mass spectrometry—to advance discoveries toward clinical impact. Calico develops therapeutic approaches targeting age-related diseases including neurodegeneration, cancer, and cardiovascular conditions.

Summary

It lists 201–500 employees. It has raised $2.3B in total across 4 rounds, most recently a $1.0B Corporate Round in Jun 2018. Investors include Alphabet, AbbVie Ventures and Google.

Tech & App Stack

14 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Corporate RoundCorporate RoundJun 2018
$1.0B

Sign up to see all 4 events

Funding: Corporate Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
CertaraIPO

Global biosimulation software and services company accelerating drug development for 2,000+ bioph...

Radnor, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$1.3BDec 2022
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Calico on Indexed.vc
<a href="https://indexed.vc/companies/calico"><img src="https://indexed.vc/api/badge/company/calico" alt="Calico on Indexed.vc" width="260" height="76" /></a>